Research Professionals DCT Resources
As a leading CRO offering Decentralized Clinical Trial (DCT) services, Research Professionals shares its knowledge and perspectives regarding specialized in-home Contract Research Organization (CRO) services to interested parties. Our leadership, technical staff and managers all contribute to this sharing of knowledge through our case studies, articles, and whitepapers. Check back here often for the latest updated information on trends and topics that are relevant to clinical researchers, sponsors and CROs with regard to the conduct of DCTs.
Case studies
Integrated Clinical and Decentralized Approach to Accelerate Clinical Trials
An emerging U.S. based life science company with operations in Europe was seeking to restart and expand their stalled clinical trial came to Research Professionals for assistance. Research Professionals (RP) had built a reputation as a leading high-quality clinical research service provider with clinical management capabilities in both conventional in-clinic studies and more recently Decentralized Clinical Trials (DCTs).
Speed and Flexibility Delivered Through Decentralized Clinical Trials (DCTs)
Research Professionals (RP) clinical research service provider was engaged by a European based global pharma sponsor to conduct two pediatric psychiatric clinical studies using their established Decentralized Clinical Trials (DCTs) approach, with home nursing led capabilities.
Articles
Advantages of conducting clinical studies in Central and Eastern Europe
November 8, 2021 - Interview with Research Professionals' György BARTA who serves as Managing Partner for Research Professionals, a leading GCP compliant clinical research service provider. The interview provides insights into potential advantages to conduct clinical studies in the Central and Eastern Europe (CEE) region with clinical research service providers like Research Professionals (RP).
How to Reduce your Clinical Study Budget with Central and Eastern Europe
February, 2022 - Clinical research studies for pharmaceuticals and medical devices are complex and expensive programs. Every study can be so critical that running a good one can make the difference between your product failing or making it to market. Working with large high-quality clinical research service providers in established western markets can be very expensive to achieve high-quality study programs.